470 related articles for article (PubMed ID: 16763586)
1. A special biotech speculation.
Jacobs T
Nat Biotechnol; 2006 Jun; 24(6):622. PubMed ID: 16763586
[No Abstract] [Full Text] [Related]
2. When your stock takes a nosedive.
Jacobs T
Nat Biotechnol; 2006 Feb; 24(2):144. PubMed ID: 16465152
[No Abstract] [Full Text] [Related]
3. Great company, bad stock.
Jacobs T
Nat Biotechnol; 2005 Feb; 23(2):173. PubMed ID: 15696142
[No Abstract] [Full Text] [Related]
4. The protection racket.
Jacobs T
Nat Biotechnol; 2006 Sep; 24(9):1081. PubMed ID: 16964213
[No Abstract] [Full Text] [Related]
5. Does biotech M&A benefit investors?
Jacobs T
Nat Biotechnol; 2004 Sep; 22(9):1085. PubMed ID: 15340472
[No Abstract] [Full Text] [Related]
6. No pain, no gain?
Jacobs T
Nat Biotechnol; 2005 Aug; 23(8):934. PubMed ID: 16082357
[No Abstract] [Full Text] [Related]
7. Beware the biotech barker.
Jacobs T
Nat Biotechnol; 2005 May; 23(5):538. PubMed ID: 15877065
[No Abstract] [Full Text] [Related]
8. Biotech IPOs: handle with care.
Jacobs T
Nat Biotechnol; 2003 Dec; 21(12):1437. PubMed ID: 14647322
[No Abstract] [Full Text] [Related]
9. Paying over the odds.
Jacobs T
Nat Biotechnol; 2006 Jan; 24(1):29. PubMed ID: 16404388
[No Abstract] [Full Text] [Related]
10. More than meets the eyes?
Jacobs T
Nat Biotechnol; 2004 Oct; 22(10):1221. PubMed ID: 15470455
[No Abstract] [Full Text] [Related]
11. Is Elan a turnaround?
Jacobs T
Nat Biotechnol; 2003 Sep; 21(9):985. PubMed ID: 12949557
[No Abstract] [Full Text] [Related]
12. Hyseq-Variagenics merger signals end of the line.
Hodgson J
Nat Biotechnol; 2003 Jan; 21(1):5. PubMed ID: 12511895
[No Abstract] [Full Text] [Related]
13. Another clue to biotech value.
Jacobs T
Nat Biotechnol; 2003 Jul; 21(7):746. PubMed ID: 12833091
[No Abstract] [Full Text] [Related]
14. Hedge funds gain edge by doubling biotech investments.
Ransom J
Nat Biotechnol; 2006 Apr; 24(4):373-4. PubMed ID: 16601707
[No Abstract] [Full Text] [Related]
15. Divining the path to a successful European exit.
Buch HK; Gustafsson AC; Drvota V; Sundberg CJ
Nat Biotechnol; 2011 Mar; 29(3):205-7. PubMed ID: 21510008
[No Abstract] [Full Text] [Related]
16. My worst biotech investment.
Jacobs T
Nat Biotechnol; 2006 Apr; 24(4):401. PubMed ID: 16601718
[No Abstract] [Full Text] [Related]
17. Biotech holds steady in Q4.
Mitchell P
Nat Biotechnol; 2004 Feb; 22(2):135-6. PubMed ID: 14755275
[No Abstract] [Full Text] [Related]
18. UK biotech sector loses flagship PowderJect to Chiron.
Mitchell P
Nat Biotechnol; 2003 Jul; 21(7):717. PubMed ID: 12833073
[No Abstract] [Full Text] [Related]
19. Biotech IPOs--flop or pop?
Jacobs T
Nat Biotechnol; 2004 Aug; 22(8):949. PubMed ID: 15286641
[No Abstract] [Full Text] [Related]
20. Biotechs for pennies?
Jacobs T
Nat Biotechnol; 2004 Dec; 22(12):1509. PubMed ID: 15583652
[No Abstract] [Full Text] [Related]
[Next] [New Search]
